| BAC | 3.15% | 50.49 | +0.22% | 1,288 | |
| META | 2.98% | 751.11 | +0.50% | 80 | |
| GS | 2.92% | 751.22 | +0.21% | 80 | |
| WFC | 2.92% | 81.98 | -0.63% | 736 | |
| CSCO | 2.89% | 69.43 | +1.45% | 872 | |
| T | 2.77% | 28.94 | -0.41% | 1,952 | |
| DIS | 2.70% | 117.64 | -0.38% | 464 | |
| VZ | 2.69% | 43.93 | -0.77% | 1,232 | |
| COP | 2.56% | 98.45 | +0.56% | 528 | |
| C | 2.55% | 96.82 | -0.05% | 544 |
Crossmark ETF Trust - Crossmark Large Cap Value ETF is an exchange traded fund launched and managed by Crossmark Global Investments, Inc. It invests in public equity markets. The fund invests in stocks of companies operating across diversified sectors. The fund invests in value stocks of large-cap companies, within the market capitalization range of the Russell 1000 Value Index. It invests in stocks of companies that are deemed socially conscious in their business dealings. The fund employs fundamental and quantitative analysis to create its portfolio. The fund does not invest in stocks of companies operating across production, distribution, retail, supply or licensing of alcohol or related products, tobacco or related products, gambling, abortions and/or the production of drugs that are used to terminate pregnancy, leasing real estate to facilities providing abortions, scientific research using stem cells derived from human embryos, fetal tissue or human embryo cloning techniques, production of adult entertainment or materially involved in the distribution or retail of adult entertainment, production, distribution, retail, supply or licensing of psychoactive recreational cannabis or derivative products sectors. The fund employs external research to create its portfolio. Crossmark ETF Trust - Crossmark Large Cap Value ETF was formed on July 23, 2025 and is domiciled in the United States.